Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ISA 2020 | Daratumumab in the management of AL amyloidosis

Morie Gertz • 23 Sep 2020
ISA 2020
Amyloidosis Rare Diseases Antibodies Bortezomib Cyclophosphamide Daratumumab Dexamethasone Isatuximab Ixazomib Lenalidomide Melphalan

Daratumumab may be a promising treatment for newly-diagnosed patients with light chain (AL) amyloidosis. Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, discusses the drug treatment options in AL amyloidosis, specifically focussing on the role of daratumumab. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Morie Gertz

Amyloidosis Sessions: Highlights from ISA 2022
Morie Gertz et al. • 6 Sep 2022
Results from VITAL: survival benefit of birtamimab in Mayo Stage IV AL amyloidosis 1:36
Results from VITAL: survival benefit of birtamimab in Mayo Stage IV AL amyloidosis
Morie Gertz • 21 Nov 2022
The role of allogeneic transplantation in patients with multiple myeloma 1:33
The role of allogeneic transplantation in patients with multiple myeloma
Morie Gertz • 21 Nov 2022
The importance of identifying AH amyloidosis in patients with normal free light chain levels 1:34
The importance of identifying AH amyloidosis in patients with normal free light chain levels
Morie Gertz • 21 Nov 2022

Related Videos

Refining the diagnosis and classification of CMML 6:25
Refining the diagnosis and classification of CMML
Guillermo Montalban-Bravo et al. • 20 Sep 2025
Improving the diagnosis of amyloidosis: advice that can be applied in practice 2:48
Improving the diagnosis of amyloidosis: advice that can be applied in practice
Gareth Morgan • 18 Sep 2025
Ongoing research in gray zone lymphoma 1:07
Ongoing research in gray zone lymphoma
Kieron Dunleavy • 4 Sep 2025
Insights into gray zone lymphoma: a rare subtype of NHL 1:14
Insights into gray zone lymphoma: a rare subtype of NHL
Kieron Dunleavy • 4 Sep 2025
The content of VJHemOnc is intended for healthcare professionals